Literature DB >> 11394662

Alphafetoprotein: an obituary.

M Sherman.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11394662     DOI： 10.1016/s0168-8278(01)00025-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  59 in total

1.  Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.

Authors:  Lorenzo Andreana; Graziella Isgrò; Maria Pleguezuelo; Giacomo Germani; Andrew K Burroughs
Journal:  World J Hepatol       Date:  2009-10-31

2.  Clinical diagnosis and treatment of alpha-fetoprotein-negative small hepatic lesions.

Authors:  Yiyao Xu; Xin Lu; Yilei Mao; Xinting Sang; Haitao Zhao; Shunda Du; Haifeng Xu; Yongliang Sun; Huayu Yang; Tianyi Chi; Zhiying Yang; Shouxian Zhong; Jiefu Huang
Journal:  Chin J Cancer Res       Date:  2013-08       Impact factor: 5.087

3.  Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists.

Authors:  Pratima Sharma; Sameer D Saini; Latoya B Kuhn; Joel H Rubenstein; Darrell S Pardi; Jorge A Marrero; Philip S Schoenfeld
Journal:  Dig Dis Sci       Date:  2010-10-27       Impact factor: 3.199

4.  Should AFP (or any biomarkers) be used for HCC surveillance?

Authors:  Hager F Ahmed Mohammed; Lewis R Roberts
Journal:  Curr Hepatol Rep       Date:  2017-04-28

5.  HCC-DETECT: a combination of nuclear, cytoplasmic, and oncofetal proteins as biomarkers for hepatocellular carcinoma.

Authors:  Abdelfattah M Attallah; Mohamed El-Far; Camelia A Abdel Malak; Mohamed M Omran; Gamal E Shiha; Khaled Farid; Lamiaa A Barakat; Mohamed S Albannan; Ahmed A Attallah; Mohamed A Abdelrazek; Mohamed S Elbendary; Refaat Sabry; Gehan A Hamoda; Mohamed M Elshemy; Abdallah A Ragab; Basma M Foda; Sanaa O Abdallah
Journal:  Tumour Biol       Date:  2015-05-01

Review 6.  Surveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver Cirrhosis.

Authors:  Jens U Marquardt; Marc Nguyen-Tat; Peter R Galle; Marcus A Wörns
Journal:  Visc Med       Date:  2016-04-08

7.  HBV/A and HBV/C genotype predominance among patients with chronic hepatitis B virus infection in Cebu City, Philippines.

Authors:  Karen S Batoctoy; Tai-Chung Tseng; Jia-Horng Kao; Fidelis E Quiza; Lamberto H Garcia; Judy Lao-Tan
Journal:  Hepatol Int       Date:  2011-03-19       Impact factor: 6.047

8.  Assessment of treatment outcomes based on tumor marker trends in patients with recurrent hepatocellular carcinoma undergoing trans-catheter arterial chemo-embolization.

Authors:  Takuma Arai; Akira Kobayashi; Ayumi Ohya; Masaaki Takahashi; Takahide Yokoyama; Akira Shimizu; Hiroaki Motoyama; Norihiko Furusawa; Tsuyoshi Notake; Noriyuki Kitagawa; Hiroshi Sakai; Hiroshi Imamura; Masumi Kadoya; Shin-Ichi Miyagawa
Journal:  Int J Clin Oncol       Date:  2013-11-12       Impact factor: 3.402

9.  Expression of protein kinase C family in human hepatocellular carcinoma.

Authors:  Hsiu-Chin Lu; Fen-Pi Chou; Kun-Tu Yeh; Ya-Sian Chang; Nicholas C Hsu; Jan-Gowth Chang
Journal:  Pathol Oncol Res       Date:  2009-12-01       Impact factor: 3.201

10.  A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease.

Authors:  Joe Gray; Dipankar Chattopadhyay; Gary S Beale; Gillian L Patman; Luca Miele; Barry P King; Stephen Stewart; Mark Hudson; Christopher P Day; Derek M Manas; Helen L Reeves
Journal:  BMC Cancer       Date:  2009-08-05       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.